ÂÜÀòÂÒÂ×

Gert Veldhuis is an experienced professional in business development and consultancy, currently serving as an Advisor to the Board and Chief Business Development Officer at Uneedle since January 2018, focusing on silicon microneedles for intradermal injection. Since April 2016, Gert has been a free agent at Pragmates, providing consultancy, supervision, management, and investment services. Previous roles include Manager of Operations at Nanomi from October 2004 to March 2016, leading the company after its acquisition by Lupin. Gert co-founded C2V and acted as Managing Director from 2001 to 2004, and has held various positions including Contract Manager at Kymata/Alcatel/Avanex, Project Leader at Philips Research, and Senior Researcher. Gert Veldhuis earned a PhD in Applied Physics from the University of Twente, where studies were completed from 1988 to 1998.